Stem cell-derived dopaminergic cell transplantation shows encouraging results for Parkinson's disease

https://www.news-medical.net/news/20260709/Stem-cell-derived-dopaminergic-cell-transplantation-shows-encouraging-results-for-Parkinsons-disease.aspx The International Society for Stem Cell Research (ISSCR) today announced the presentation of new clinical data from the STEM-PD Phase I/II clinical trial at the ISSCR 2026 Annual Meeting. The study reports 12-month outcomes evaluating a cryopreserved, off-the-shelf dopaminergic progenitor cell product derived from human pluripotent stem cells for the treatment of Parkinson's disease.